Therapeutic areas
Clinical development decisions must reflect the disease, the patient population and the treatment pathway. Clarenta brings therapeutic understanding into study strategy and delivery, helping sponsors anticipate challenges and interpret evidence in the right clinical context.
Our experience spans oncology and onco-haematology, rare diseases, neurology and psychiatry, respiratory diseases, dermatology, gastroenterology and other complex therapeutic areas.
Clinical trial case studies
The clearest measure of experience is how it supports real clinical development. Our case studies show how Clarenta teams have responded to demanding study requirements, addressed operational challenges and helped sponsors reach important milestones.
Explore the decisions behind the work, the approach taken and the outcomes achieved across early and later phase clinical trials.
Client testimonials
Strong partnerships are built through transparency, accessibility and reliable delivery. Hear directly from the biotech and pharmaceutical teams that have worked with Clarenta across complex clinical trials.
Their perspectives reflect what matters in practice: clear communication, responsive teams and the confidence of knowing where a study stands and what comes next.
Certifications that make quality visible
Our certifications provide independent assurance that the systems behind our clinical research, Phase I Unit and laboratory operations meet recognised quality and regulatory standards. They reflect the controls, oversight and continuous improvement that support reliable delivery across your programme.
About Clarenta
Clarenta is a European CRO supporting biotech and pharmaceutical companies through complex clinical development. We combine strategic guidance, scientific expertise and operational delivery to help sponsors make informed decisions and move forward with greater clarity.
Across 29 years and more than 950 clinical trials, our teams have built experience grounded in the realities of clinical research—while remaining accessible, accountable and close to every study we support.